The Pharmacogenomics Journal - Table of Contents alert Volume 13 Issue 4

TABLE OF CONTENTS Volume 13, Issue 4 (August 2013) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Wondering where to publish your next paper?  Frontiers is a community-oriented open-access publisher and research network. We are driving innovations around peer-review and a whole ecosystem of open science tools.  Be a part of the future of research publication     Review Top Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases R Prieto-Pérez, T Cabaleiro, E Daudén and F Abad-Santos Pharmacogenomics J 2013 13: 297-305; advance online publication, January 22, 2013; 10.1038/tpj.2012.53 Abstract | Full Text Original Articles Top Predicting inhaled corticosteroid response in asthma with two associated SNPs M J McGeachie, A C Wu, H-H Chang, J J Lima, S P Peters and K G Tantisira Pharmacogenomics J 2013 13: 306-311; advance online publication, May 29, 2012; 10.1038/tpj.2012.15 Abstract | Full Text The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study A C Frazier-Wood, J M Ordovas, R J Straka, J E Hixson, I B Borecki, H K Tiwari and D K Arnett Pharmacogenomics J 2013 13: 312-317; advance online publication, May 1, 2012; 10.1038/tpj.2012.9 Abstract | Full Text Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial F H van der Baan, M J Knol, A H Maitland-van der Zee, J J Regieli, E P A van Iperen, A C G Egberts, O H Klungel, D E Grobbee and J W Jukema Pharmacogenomics J 2013 13: 318-324; advance online publication, May 1, 2012; 10.1038/tpj.2012.12 Abstract | Full Text Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes A H Ramirez, C M Shaffer, J T Delaney, D P Sexton, S E Levy, M J Rieder, D A Nickerson, A L George, Jr and D M Roden Pharmacogenomics J 2013 13: 325-329; advance online publication, May 15, 2012; 10.1038/tpj.2012.14 Abstract | Full Text RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment A I Lynch, M R Irvin, E Boerwinkle, B R Davis, L K Vaughan, C E Ford, B Aissani, J H Eckfeldt, D K Arnett and S Shrestha Pharmacogenomics J 2013 13: 330-334; advance online publication, June 5, 2012; 10.1038/tpj.2012.22 Abstract | Full Text Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin I Iacobucci, A Lonetti, A Candoni, M Sazzini, C Papayannidis, S Formica, E Ottaviani, A Ferrari, A Michelutti, E Simeone, A Astolfi, M C Abbenante, S Parisi, F Cattina, M Malagola, D Russo, D Damiani, F Gherlinzoni, M Gottardi, M Baccarani, R Fanin and G Martinelli Pharmacogenomics J 2013 13: 335-341; advance online publication, May 15, 2012; 10.1038/tpj.2012.13 Abstract | Full Text An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrence T Winder, P M Wilson, D Yang, W Zhang, Y Ning, D G Power, P Bohanes, A Gerger, L H Tang, M Shah and H-J Lenz Pharmacogenomics J 2013 13: 342-348; advance online publication, April 10, 2012; 10.1038/tpj.2012.11 Abstract | Full Text ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder O L de Klerk, I M Nolte, P M Bet, F J Bosker, H Snieder, J A den Boer, R Bruggeman, W J Hoogendijk and B W Penninx Pharmacogenomics J 2013 13: 349-353; advance online publication, May 29, 2012; 10.1038/tpj.2012.16 Abstract | Full Text Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder D Sasayama, A Hiraishi, M Tatsumi, K Kamijima, M Ikeda, W Umene-Nakano, R Yoshimura, J Nakamura, N Iwata and H Kunugi Pharmacogenomics J 2013 13: 354-358; advance online publication, May 15, 2012; 10.1038/tpj.2012.18 Abstract | Full Text Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms P Dorado, E López-Torres, E M Peñas-LLedó, J Martínez-Antón and A LLerena Pharmacogenomics J 2013 13: 359-361; advance online publication, May 29, 2012; 10.1038/tpj.2012.19 Abstract | Full Text Transgenic mouse model reveals an unsuspected role of the acetylcholine receptor in statin-induced neuromuscular adverse drug reactions G E Grajales-Reyes, C A Báez-Pagán, H Zhu, J G Grajales-Reyes, M Delgado-Vélez, W F García-Beltrán, C A Luciano, O Quesada, R Ramírez, C M Gómez and J A Lasalde-Dominicci Pharmacogenomics J 2013 13: 362-368; advance online publication, June 12, 2012; 10.1038/tpj.2012.21 Abstract | Full Text Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes S Martis, I Peter, J-S Hulot, R Kornreich, R J Desnick and S A Scott Pharmacogenomics J 2013 13: 369-377; advance online publication, April 10, 2012; 10.1038/tpj.2012.10 Abstract | Full Text Clinical and economic challenges facing pharmacogenomics J Cohen, A Wilson and K Manzolillo Pharmacogenomics J 2013 13: 378-388; advance online publication, January 10, 2012; 10.1038/tpj.2011.63 Abstract | Full Text Advertisement Naturejobs presents the: Naturejobs Career Expo September 19, 2013 The Business Design Centre, London, UK  Click here for more information or to register for this conference today!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.